|
|
Nanoemulsion-Based Intranasal Influenza Vaccine Adjuvant Triggers Robust Immunity Using Significantly Less Antigen (PR Newswire via Yahoo! Finance)
A single administration of a novel, nasally delivered influenza vaccine elicited immune responses in ferrets that were more than 20 times higher than those generated by two injections of the currently approved vaccines, according to a study by NanoBio Corporation.
Pocket Doc (Chicago Flame)
Dr. George Q. Do I really have to drink eight glasses of water a day? A. No. The "eight glasses of water a day" myth is right up there with the "don't go outside with wet hair" and "don't swim for 30 minutes after eating" myths as the most repeated. Interestingly, other than from our Moms, we really don't have any idea where they have come from.
Late-night TV just rubbish? Stiff! (Blayney Chronicle)
THE future of television has arrived and it goes by the name of Guthy-Renker. Or sometimes Danoz Direct. Or any of the other companies which pay for hours of free-to-air TV time to flog their wares.
Author encounters, exposes dangers of acedia (Rapid City Journal)
South Dakota?s most famous Benedictine oblate has written a new book about spiritual sloth, which, she says, took her years to complete.
NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy (PR Newswire via Yahoo! Finance)
A novel topical therapy for nail fungus, NB-002, has demonstrated a new topical approach to healing nail fungus by penetrating skin pores and diffusing through the skin that surrounds the entire nail plate, according to a study conducted by NanoBio Corporation.
The Most Effective Ways to Treat and Prevent Acne (Carteret County News-Times)
(ARA) - Image is everything for a lot of guys. Whether you want to look good for a date, impress the ladies at the nightclub or present a professional image in the workplace, the last thing you need is for a pimple to appear on your face.
Dusa reports results from Phase IIb acne trial (Pharmaceutical Business Review)
Dusa Pharmaceuticals, an integrated dermatology pharmaceutical company, has announced results from its Phase IIb clinical trial to compare the safety and efficacy of photodynamic therapy using the companys Blu-U brand light plus vehicle containing Levulan to that of photodynamic therapy using the Blu-U plus vehicle without Levulan in patients with moderate to severe facial acne vulgaris.
|
Back to Information on Acne
Back to Acne News Arc |
|
|
